Driven PCK1 expression in glucose-starved liver cancer cells has been shown in studies to induce tricarboxylic acid cycle (TCA) cataplerosis, resulting in an energy deficiency and oxidative stress, whereas supplementation of ketoglutarate or suppression of reactive oxygen species can prevent cell death provoked by PEPCK expression6. Here, PCK2 is linked to liver cancer.